文献速递皮肤肿瘤

隆突性皮肤纤维肉瘤的最佳手术治疗是什么?

What is the best surgical treatment for dermatofibrosarcoma protuberans?
PubMed 文献 · Br J Dermatol · 2021-01-01

本研究基于英国11个整形外科和15个皮肤科2004至2013年收治的483例新发和64例复发隆突性皮肤纤维肉瘤(DFSP)病例,分析宽局部切除(WLE)与莫氏显微手术(MMS)的应用及复发情况。中位随访新发DFSP略超2年、复发DFSP 1.6年后,WLE后6例复发,MMS后无复发,但两种手术方法的复发差异无统计学意义。

要点

  • 新发DFSP中约75%采用WLE、20%采用MMS;复发DFSP中69%采用WLE、23%采用MMS。
  • 随访期间WLE后6例肿瘤复发,MMS后无复发,但统计学未见显著差异。
  • 在更详细研究数据可用前,DFSP术式选择应基于患者偏好、治疗可及性和费用。

核心结论

  • MMS后未观察到DFSP复发,但研究未能检测出WLE与MMS之间复发率的显著差异。
  • 目前DFSP治疗选择应基于患者偏好、治疗可及性和费用。

研究设计与样本

  • 共纳入483例新发和64例复发DFSP,合计547例手术,分析所采用的手术方法。

主要发现

  • 新发DFSP中近75%采用WLE、20%采用MMS;复发DFSP中69%采用WLE、23%采用MMS。
  • 新发DFSP中位随访略超2年、复发DFSP中位随访1.6年后,WLE后6例复发,MMS后无复发。

关键数值与推荐

  • WLE切除范围通常为肿瘤周围1-5 cm预定边缘。
  • MMS切除肿瘤及较小边缘后立即显微镜检查切缘,对仍有肿瘤细胞的区域重复切除直至切缘无肿瘤细胞。

临床怎么用

  • DFSP手术方式可选择WLE或MMS,需结合患者偏好、治疗可及性和费用进行个体化决策。

局限性

  • 研究未能检测出两种手术方法间复发率的显著差异。
  • 需等待更详细研究数据以进一步明确最佳手术方式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Dermatofibrosarcoma protuberans (DFSP) is a rare, slow-growing skin cancer that is primarily treated with surgery. Because this cancer can spread deep into the skin and surrounding tissue in an irregular way, it is notoriously difficult to ensure that it has been completely removed after conventional surgery and histological examination. Standard treatment in the UK is either wide local excision (WLE) or Mohs micrographic surgery (MMS). In WLE, the tumour and a predetermined margin of skin around it is removed. The margin is usually in the range of 1-5 cm. MMS involves removing the tumour and a much smaller margin around it, followed by immediate microscopic examination of the edges of the removed skin. Areas still containing tumour cells are then removed. This is repeated until all the edges are clear of tumour cells. This method allows the surgeon to track the tumour and only remove tissue where is it present. This study was carried out at several centres in the UK. Clinical records were examined of cases of DFSP between 1 January 2004 and 31 December 2013. This study includes the largest number of cases of DFSP reported in the UK: 483 new and 64 recurring cases of DFSP, in 11 plastic surgery and 15 dermatology departments. The methods used to perform these 547 surgeries were analysed. Almost 75% of cases of new DFSP were treated with WLE and 20% were treated with MMS. For recurring DFSP, 69% of patients had WLE and 23% had MMS. After a median follow-up period of just over 2 years for new DFSP and 1.6 years for recurring DFSP, the tumour returned in six patients after WLE and none after MMS. Although no DFSP were found to have returned after MMS, the study could not detect any significant difference in recurrences between the two surgical methods. Until data from more detailed studies are available, the choice of treatment for DFSP should be based on the patient's preference, treatment availability and cost. Linked Article: Durack et al. Br J Dermatol 2021; 184:731-739.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. What is the best surgical treatment for dermatofibrosarcoma protuberans? Br J Dermatol. 2021. PMID: 33835484. doi:10.1111/bjd.19837

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。